NUROFIL-ALA
(Mecobalamin, Alpha Lipoic Acid, Folic Acid and Pyridoxine Hydrochloride Softgel Capsules)
Composition:
Each softgel capsules contains:
Mecobalamin                           IP                   1500 mcg
Alpha Lipoic Acid                     USP               100 mg
Folic Acid                                   IP                   1.5 mg
Pyridoxine Hydrochloride      IP                    3 mg
Excipients                                                          q.s.
Packaging:
1 × 10 Soft Gelatin Capsules
Description
NUROFIL-ALA is a comprehensive neuro-nutritional formulation enriched with Mecobalamin, Alpha Lipoic Acid, Folic Acid, and Pyridoxine Hydrochloride that works synergistically to promote nerve health and regeneration. Mecobalamin helps repair damaged nerves and restore the myelin sheath, improving nerve conduction and reducing neuropathic symptoms. Alpha Lipoic Acid acts as a powerful antioxidant that reduces oxidative stress and protects nerve cells from free radical damage. Folic Acid supports DNA synthesis and healthy nerve cell function, while Pyridoxine Hydrochloride aids neurotransmitter synthesis and maintains normal nerve metabolism.
NUROFIL-ALA is beneficial in diabetic neuropathy, peripheral neuropathy, and vitamin deficiency–related neurological disorders. It helps relieve numbness, tingling, burning sensation, and nerve pain while supporting nerve repair, regeneration, and overall neurological wellness. The formulation also helps improve cellular energy metabolism and provides nutritional support for healthy nerve function.
Indications:
- Management of peripheral neuropathy and diabetic neuropathy
- Helps reduce numbness, tingling, burning, and nerve pain
- Supports nerve repair and regeneration
- Used in vitamin B12, folate, and vitamin B6 deficiency states
- Provides antioxidant support in nerve-related disorders
Therapeutic Segment Positioning:
Neurological Health
Be the first to review “NUROFIL-ALA”
You must be logged in to post a review.







Reviews
There are no reviews yet.